Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Gene Med. 2011 Oct;13(10):557-65. doi: 10.1002/jgm.1600.

The evolution of heart gene delivery vectors.

Author information

  • 1Department of Molecular Microbiology and Immunology, University of Missouri, Columbia, MO 65212, USA.

Abstract

Gene therapy holds promise for treating numerous heart diseases. A key premise for the success of cardiac gene therapy is the development of powerful gene transfer vehicles that can achieve highly efficient and persistent gene transfer specifically in the heart. Other features of an ideal vector include negligible toxicity, minimal immunogenicity and easy manufacturing. Rapid progress in the fields of molecular biology and virology has offered great opportunities to engineer various genetic materials for heart gene delivery. Several nonviral vectors (e.g. naked plasmids, plasmid lipid/polymer complexes and oligonucleotides) have been tested. Commonly used viral vectors include lentivirus, adenovirus and adeno-associated virus. Among these, adeno-associated virus has shown many attractive features for pre-clinical experimentation in animal models of heart diseases. We review the history and evolution of these vectors for heart gene transfer.

Copyright © 2011 John Wiley & Sons, Ltd.

PMID:
21837689
[PubMed - indexed for MEDLINE]
PMCID:
PMC3292875
Free PMC Article

Images from this publication.See all images (2)Free text

Figure 1
Figure 2
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for John Wiley & Sons, Inc. Icon for PubMed Central
    Loading ...
    Write to the Help Desk